SSA
SLDB icon

Schonfeld Strategic Advisors’s Solid Biosciences SLDB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,493
Closed -$220K – 2967
2026
Q1 		$220K Sell
30,493
-152,376
-83% -$979K ﹤0.01% 1703
2025
Q4 		$1.03M Buy
182,869
+114,867
+169% +$623K ﹤0.01% 1114
2025
Q3 		$420K Buy
+68,002
New +$398K ﹤0.01% 1732
2021
Q2 		– Sell
-8,721
Closed -$723K – 2270
2021
Q1 		$723K Buy
+8,721
New +$965K 0.01% 1013
2019
Q3 		– Sell
-3,147
Closed -$271K – 1217
2019
Q2 		$271K Buy
+3,147
New +$343K 0.01% 807

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Schonfeld Strategic Advisors's SLDB Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of Solid Biosciences (SLDB) in Q2 2026, closing a stake of 30,493 shares — an estimated $220K sold.

Schonfeld Strategic Advisors first reported a position in SLDB in Q2 2019 and held it in 5 quarters. The position peaked at $1.03M in Q4 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining Solid Biosciences position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 30,493 Solid Biosciences shares in Q2 2026, an estimated $220K.
  • Schonfeld Strategic Advisors first reported a position in Solid Biosciences in Q2 2019 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's Solid Biosciences position peaked at $1.03M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.